Bizjournals -- World Heart Corp. said Friday it has completed a $30 million private placement and recapitalization agreement that could help the company advance late-stage testing of its Novacor LVAS heart pump this year.
Bizjournals -- World Heart Corp. said Friday it has completed a $30 million private placement and recapitalization agreement that could help the company advance late-stage testing of its Novacor LVAS heart pump this year.
